Cart
sales@molnova.com
(Z)-SU4312
CAS No. 90828-16-3
(Z)-SU4312( —— )
Catalog No. M20364 CAS No. 90828-16-3
(Z)-SU4312 is a inhibitor of MAO-B and NOS(IC50 value of 0.2 μM 19.0μMrespectively).
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 113 | In Stock |
|
| 5MG | 119 | In Stock |
|
| 10MG | 181 | In Stock |
|
| 25MG | 297 | In Stock |
|
| 50MG | 410 | In Stock |
|
| 100MG | 542 | In Stock |
|
| 200MG | 728 | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product Name(Z)-SU4312
-
NoteResearch use only, not for human use.
-
Brief Description(Z)-SU4312 is a inhibitor of MAO-B and NOS(IC50 value of 0.2 μM 19.0μMrespectively).
-
Description(Z)-SU4312 is a inhibitor of MAO-B and NOS(IC50 value of 0.2 μM 19.0μMrespectively).
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayMetabolic Enzyme/Protease
-
TargetMAO
-
RecptorMAO-B|NOS
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number90828-16-3
-
Formula Weight264.32
-
Molecular FormulaC17H16N2O
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESCN(C)c1ccc(cc1)\C=C1/C(=O)Nc2ccccc12
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Cui W Zhang Z Li W et al. The anti-cancer agent SU4312 unexpectedly protects against MPP(+) -induced neurotoxicity via selective and direct inhibition of neuronal NOS[J].Br J Pharmacol. 2013 Mar;168(5):1201-14.
molnova catalog
related products
-
Hydroxyamine hydroch...
Hydroxyamine hydrochloride(Hydroxylammonium chloride) is a selective and potent monoamine oxidase (MAO) inhibitor with inhibitory effects on platelet aggregation.
-
MD 69276
MD 69276 (Toloxatone) is a reversible monoamine oxidase A (MAOA) inhibitor.
-
MAO-B-IN-8
MAO-B-IN-8 is a highly potent and reversible inhibitor of monoamine oxidase-B (MAO-B), also inhibiting microglial production of neuroinflammatory mediators. This compound is specifically designed for research on neurodegenerative diseases .
